Kaisa Health Group Holdings Limited - Laporan Laba Rugi (TTM)

Kaisa Health Group Holdings Limited
HK ˙ SEHK ˙ BMG5963A1045
HK$ 0.02 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Kaisa Health Group Holdings Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 196 184 197 211 210 210 205 200 196 191 191 190 188 186 184 182 184 185 176 166
Change (%) -6.41 7.37 6.87 -0.30 -0.31 -2.22 -2.27 -2.20 -2.25 -0.36 -0.36 -1.11 -1.12 -1.10 -1.11 0.98 0.97 -5.11 -5.38
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 101 94 99 104 108 112 115 117 113 109 109 109 107 105 103 101 102 103 100 97
Change (%) -6.95 5.31 5.04 4.05 3.89 2.15 2.11 -3.46 -3.59 -0.01 -0.01 -1.89 -1.92 -1.61 -1.63 1.01 1.00 -3.03 -3.13
% of Revenue 51.35 51.06 50.07 49.22 51.37 53.53 55.92 58.42 57.67 56.88 57.09 57.29 56.84 56.38 56.09 55.80 55.82 55.84 57.06 58.42
Gross Operating Profit 96 90 99 107 102 97 90 83 83 83 82 81 81 81 81 80 81 82 76 69
Change (%) -5.84 9.53 8.70 -4.52 -4.74 -7.25 -7.82 -0.44 -0.44 -0.83 -0.84 -0.07 -0.07 -0.44 -0.44 0.93 0.92 -7.73 -8.38
% of Revenue 48.65 48.94 49.93 50.78 48.63 46.47 44.08 41.58 42.33 43.12 42.91 42.71 43.16 43.62 43.91 44.20 44.18 44.16 42.94 41.58
SG&A 116 112 118 125 141 158 161 163 150 137 127 117 113 108 109 106 97 93 89 86
Change (%) -3.54 5.83 5.51 13.37 11.79 1.58 1.56 -7.90 -8.57 -7.40 -7.99 -3.87 -4.03 0.85 -2.94 -8.14 -4.62 -3.38 -3.50
% of Revenue 58.97 60.78 59.91 59.15 67.27 75.43 78.36 81.43 76.69 71.74 66.67 61.57 59.85 58.09 59.23 58.14 52.89 49.96 50.87 51.88
R&D 8 17 15 12 12 12
Change (%) 100.00 -14.87 -3.23 -3.33
% of Revenue 4.48 9.06 7.98 6.73 6.86 7.01
OpEx 241 226 237 249 268 288 293 298 281 264 253 242 236 230 229 224 214 209 202 195
Change (%) -6.08 5.02 4.78 7.81 7.24 1.90 1.87 -5.82 -6.18 -4.14 -4.32 -2.54 -2.61 -0.32 -2.12 -4.37 -2.65 -3.20 -3.31
% of Revenue 122.54 122.96 120.27 117.93 127.52 137.17 142.95 149.00 143.49 137.72 132.50 127.25 125.41 123.53 124.50 123.23 116.71 112.53 114.79 117.31
Operating Income -44 -42 -40 -38 -58 -78 -88 -98 -85 -72 -62 -52 -48 -44 -45 -42 -31 -23 -26 -29
Change (%) -4.64 -5.21 -5.50 53.06 34.67 12.99 11.50 -13.21 -15.22 -14.15 -16.48 -7.78 -8.43 2.97 -6.25 -27.37 -24.27 12.02 10.73
% of Revenue -22.54 -22.96 -20.27 -17.93 -27.52 -37.17 -42.95 -49.00 -43.49 -37.72 -32.50 -27.25 -25.41 -23.53 -24.50 -23.23 -16.71 -12.53 -14.79 -17.31
Interest Expense -1 -1 -1 -1 -5 -8 -10 -12 -10 -8 -7 -7 -5 -4 -2 -1 -1 -1 -1 -1
Change (%) 37.25 13.43 11.84 246.70 71.16 21.44 17.66 -16.93 -20.39 -6.87 -7.37 -22.49 -29.01 -35.60 -55.28 -13.15 -15.14 -11.62 -13.14
% of Revenue -0.40 -0.59 -0.62 -0.65 -2.27 -3.90 -4.85 -5.84 -4.96 -4.04 -3.77 -3.51 -2.75 -1.97 -1.29 -0.58 -0.50 -0.42 -0.39 -0.36
Net Income -203 -40 -6 27 15 2 -76 -155 -139 -123 -55 14 11 7 -25 -57 -52 -46 -39 -31
Change (%) -80.44 -84.05 -526.80 -45.64 -83.94 -3,342.16 103.08 -10.30 -11.49 -55.55 -125.00 -22.74 -29.44 -430.27 130.28 -9.19 -10.12 -16.33 -19.52
% of Revenue -103.31 -21.59 -3.21 12.81 6.99 1.13 -37.31 -77.53 -71.11 -64.40 -28.73 7.21 5.63 4.02 -13.42 -31.24 -28.09 -25.01 -22.05 -18.76

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista